William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form NPORT-P WILLIAM BLAIR FUNDS For: Dec 31
-
Form 497 WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 485BPOS WILLIAM BLAIR FUNDS
-
Form N-CSR WILLIAM BLAIR FUNDS For: Dec 31
-
Form X-17A-5 WILLIAM BLAIR & COMPANY For: Dec 31
-
William Blair Reiterates Biohaven Pharmaceutical (BHVN) at Outperform, Nurtec ODT Will Eventually Become Blockbuster Franchise
-
Form D WILLIAM BLAIR MB INVESTM
-
William Blair Reiterates BioMarin Pharmaceutical (BMRN) at Outperform, "The Company Has a Promising Growth Profile"
-
RingCentral (RNG) Delivers a 'Clean Q4 Beat', Analysts See More Upside in 2022
-
Priority Income Fund, Inc. Prices Offering of Preferred Stock
-
Priority Income Fund, Inc. Prices Offering of Preferred Stock
-
Form D WILLIAM BLAIR MB INVESTM
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Priority Income Fund, Inc. Launches Preferred Stock Offering
-
Priority Income Fund, Inc. Launches Preferred Stock Offering
-
Form 485BPOS WILLIAM BLAIR FUNDS
-
Form 485BPOS WILLIAM BLAIR FUNDS
-
Vera Whole Health, Inc. Completes Acquisition of Castlight Health, Inc.
-
Toast (TOST) Shares Plunge 15% After Missing Guidance Targets, Analyst Remains Bullish
-
Toast Inc. (TOST) Doubles Down on Initiatives, William Blair Doubles Down and Would be a Buyer
-
Cellebrite Announces Fourth Quarter and Full Year 2021 Results
-
Cellebrite Announces Fourth Quarter and Full Year 2021 Results
-
William Blair Reiterates Market Perform Rating on Allakos Inc. (ALLK), lirentelimab May Still Have Path for Approval in EGIDs
-
William Blair Reiterates Outperform Rating on Alteryx (AYX), Sees Stock as Materially Undervalued and as a Buying Opportunity
-
Twist Bioscience Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Wellington Management Announces Strategic Expansion of Alternative Investment Resources
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497 WILLIAM BLAIR FUNDS
-
Form 497 WILLIAM BLAIR FUNDS
-
Form 13F-HR BLAIR WILLIAM & CO/IL For: Dec 31
-
GoDaddy Inc (GDDY) Investor Day Takeaways - William Blair
-
Form 13F-HR WILLIAM BLAIR INVESTMENT For: Dec 31
-
Form SC 13G/A OptimizeRx Corp Filed by: BLAIR WILLIAM & CO/IL
-
Form SC 13G/A HARTE HANKS INC Filed by: BLAIR WILLIAM & CO/IL
-
Form SC 13G/A AIRGAIN INC Filed by: BLAIR WILLIAM & CO/IL
-
William Blair Reiterates Outperform Rating on VistaGen Therapeutics (VTGN)
-
Twist Bioscience Corporation (TWST) Prices Upsized 4.55M Share Offering at $55/sh
-
Twist Bioscience Announces Pricing of an Upsized $250 Million Public Offering of Common Stock
-
Form SC 13G/A Revolve Group, Inc. Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SC 13G DENBURY INC Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SC 13G/A GRID DYNAMICS HOLDINGS, Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SC 13G UNIVERSAL ELECTRONICS Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SC 13G Designer Brands Inc. Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC
-
Form SC 13G/A BWX Technologies, Inc. Filed by: WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC

